论文部分内容阅读
目的探讨经尿道等离子电切术治疗良性前列腺增生的安全性和有效性。方法用经尿道等离子电切术行前列腺切除(TUPKVP)60例,术后随访1～6个月。结果手术时间(21～107)min;切除前列腺组织生(13～64)g,平均(30±25)g,输血1例,无电切综合征发生。术后1、3、6个月,最大尿流率(Qmax)由术前的(6.2±4.1)ml/s分别上升至(18.6±4.3)、(22.7±4.5)、(23.2±5.2)ml/s;国际前列腺症状评分(IPSS)由术前的(23.0±2.6)分别下降为(8.1±1.7)、(5.9±1.4)、(5.6±1.2);生活质量评分(QOL)由术前的(4.9±0.9)下降为(1.7±0.4)、(1.3±0.6)、(1.0±0.4);剩余尿量由术前的(98±76)ml分别减少至(15±6)、(12±8)、)(10±7)ml,4项指标手术前后比较差异均有统计学意义(P<0.05)。结论经尿道前列腺等离子电子电切术是一种安全性高、并发症少、疗效确切的方法。
Objective To investigate the safety and efficacy of transurethral resection of plasma in the treatment of benign prostatic hyperplasia. Methods Sixty cases of prostatectomy (TUPKVP) underwent transurethral resection of the prostate were followed up for 1-6 months. Results The operation time (21-107) min, removal of prostatic tissue (13-64 g), mean (30 ± 25) g, and transfusion in 1 patient. The maximum flow rate (Qmax) increased from (6.2 ± 4.1) ml / s to (18.6 ± 4.3), (22.7 ± 4.5) and (23.2 ± 5.2) ml / s. The International Prostate Symptom Score (IPSS) decreased from (23.0 ± 2.6) to (8.1 ± 1.7), (5.9 ± 1.4) and (5.6 ± 1.2), respectively. The quality of life (QOL) (4.9 ± 0.9) decreased to (1.7 ± 0.4), (1.3 ± 0.6) and (1.0 ± 0.4) respectively. The residual urine volume decreased from (98 ± 76) ml to (15 ± 6) and 8), (10 ± 7) ml, the four indexes had significant difference before and after operation (P <0.05). Conclusion Transurethral resection of plasma prostatectomy is a safe, less complicated and effective method.